SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-032656
Filing Date
2021-06-11
Accepted
2021-06-11 16:13:53
Documents
3
Period of Report
2021-06-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tcon-8k_20210610.htm 8-K 80963
2 EX-99.1 tcon-ex991_7.htm EX-99.1 243614
3 EX-99.2 tcon-ex992_6.htm EX-99.2 93458
  Complete submission text file 0001564590-21-032656.txt   419486
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36818 | Film No.: 211011422
SIC: 2836 Biological Products, (No Diagnostic Substances)